Ben Fidler
@benthefidler.bsky.social
Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
This is the latest edition in our ‘State of Play’ series examining hotspots of biotech research. You can read some of the others - on RNA editing, autoimmune cell therapy and more - here:
www.biopharmadive.com/news/emergin...
www.biopharmadive.com/news/emergin...
State of Play: A closer look at hotspots of emerging biotech research
This series from BioPharma Dive examines new areas of biotech investment and startup activity, like radiopharmaceuticals, obesity drugs and CAR-T for lupus.
www.biopharmadive.com
March 4, 2025 at 11:43 AM
This is the latest edition in our ‘State of Play’ series examining hotspots of biotech research. You can read some of the others - on RNA editing, autoimmune cell therapy and more - here:
www.biopharmadive.com/news/emergin...
www.biopharmadive.com/news/emergin...